EGFR and non-small cell lung carcinoma: Epidermal growth factor receptor (EGFR), a cell surface receptor tyrosine kinase, is commonly overexpressed in a variety of solid tumors, including colorectal cancers and non-small cell lung cancers, and is an attractive anticancer therapeutic target against solid tumors [4].